TY - JOUR
T1 - Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo
AU - Pievani, M.
AU - Rasser, P. E.
AU - Galluzzi, S.
AU - Benussi, L.
AU - Ghidoni, R.
AU - Sabattoli, F.
AU - Bonetti, M.
AU - Binetti, G.
AU - Thompson, P. M.
AU - Frisoni, G. B.
N1 - Funding Information:
Funding support for this work was provided in part by grants from the Italian Ministry of Health, Ricerca Finalizzata 'Sviluppo di indicatori di danno cerebrovascolare clinicamente significativo alla risonanza magnetica strutturale' (grant no. 196/2002) and 'Archivio normativo italiano di morfometria cerebrale con risonanza magnetica (40+)' (grant ICS 030.13/RF00.343). P.T. was funded by NIH grants EB008281, EB007813, AG016570.
PY - 2009/5/1
Y1 - 2009/5/1
N2 - Previous studies suggest that in Alzheimer's disease (AD) the Apolipoprotein E (APOE) ε4 allele is associated with greater vulnerability of medial temporal lobe structures. However, less is known about its effect on the whole cortical mantle. Here we aimed to identify APOE-related patterns of cortical atrophy in AD using an advanced computational anatomy technique. We studied 15 AD patients carriers (ε4+, age: 72 ± 10 SD years, MMSE: 20 ± 3 SD) and 14 non-carriers (ε4-, age: 69 ± 9, MMSE: 20 ± 5) of the ε4 allele and compared them to 29 age-and-sex matched controls (age: 70 ± 9, MMSE: 28 ± 1). Each subject underwent a clinical evaluation, a neuropsychological battery, and high-resolution MRI. UCLA's cortical pattern matching technique was used to identify regions of local cortical atrophy. ε4+ and ε4- patients showed similar performance on neuropsychological tests (p > .05, t-test). Diffuse cortical atrophy was detected for both ε4+ (p = .0001, permutation test) and ε4- patients (p = .0001, permutation test) relative to controls, and overall gray matter loss was about 15% in each patients group. Differences in gray matter loss between carriers and non-carriers mapped to the temporal cortex and right occipital pole (20% greater loss in carriers) and to the posterior cingulate, left orbitofrontal and dorsal fronto-parietal cortex (5-15% greater loss in non-carriers). APOE effect in AD was not significant (p > .74, ANOVA), but a significant APOE by region (temporal vs fronto-parietal cortex) interaction was detected (p = .002, ANOVA), in both early and late-onset patients (p < .05, ANOVA). We conclude that the ε4 allele modulates disease phenotype in AD, being associated with a pattern of differential temporal and fronto-parietal vulnerability.
AB - Previous studies suggest that in Alzheimer's disease (AD) the Apolipoprotein E (APOE) ε4 allele is associated with greater vulnerability of medial temporal lobe structures. However, less is known about its effect on the whole cortical mantle. Here we aimed to identify APOE-related patterns of cortical atrophy in AD using an advanced computational anatomy technique. We studied 15 AD patients carriers (ε4+, age: 72 ± 10 SD years, MMSE: 20 ± 3 SD) and 14 non-carriers (ε4-, age: 69 ± 9, MMSE: 20 ± 5) of the ε4 allele and compared them to 29 age-and-sex matched controls (age: 70 ± 9, MMSE: 28 ± 1). Each subject underwent a clinical evaluation, a neuropsychological battery, and high-resolution MRI. UCLA's cortical pattern matching technique was used to identify regions of local cortical atrophy. ε4+ and ε4- patients showed similar performance on neuropsychological tests (p > .05, t-test). Diffuse cortical atrophy was detected for both ε4+ (p = .0001, permutation test) and ε4- patients (p = .0001, permutation test) relative to controls, and overall gray matter loss was about 15% in each patients group. Differences in gray matter loss between carriers and non-carriers mapped to the temporal cortex and right occipital pole (20% greater loss in carriers) and to the posterior cingulate, left orbitofrontal and dorsal fronto-parietal cortex (5-15% greater loss in non-carriers). APOE effect in AD was not significant (p > .74, ANOVA), but a significant APOE by region (temporal vs fronto-parietal cortex) interaction was detected (p = .002, ANOVA), in both early and late-onset patients (p < .05, ANOVA). We conclude that the ε4 allele modulates disease phenotype in AD, being associated with a pattern of differential temporal and fronto-parietal vulnerability.
KW - Alzheimer's disease
KW - Apolipoprotein E
KW - Computational neuroanatomy
KW - Cortical atrophy
KW - MRI
UR - http://www.scopus.com/inward/record.url?scp=62049084844&partnerID=8YFLogxK
U2 - 10.1016/j.neuroimage.2009.01.009
DO - 10.1016/j.neuroimage.2009.01.009
M3 - Article
C2 - 19349226
AN - SCOPUS:62049084844
SN - 1053-8119
VL - 45
SP - 1090
EP - 1098
JO - NeuroImage
JF - NeuroImage
IS - 4
ER -